SAIEX
Price
$11.11
Change
+$0.07 (+0.63%)
Updated
Jan 17 closing price
Net Assets
210.42M
SPMGX
Price
$8.91
Change
+$0.04 (+0.45%)
Updated
Jan 17 closing price
Net Assets
1.11B
Ad is loading...

SAIEX vs SPMGX

Header iconSAIEX vs SPMGX Comparison
Open Charts SAIEX vs SPMGXBanner chart's image
Spirit of America Energy Institutional
Price$11.11
Change+$0.07 (+0.63%)
VolumeN/A
Net Assets210.42M
Invesco SteelPath MLP Alpha R
Price$8.91
Change+$0.04 (+0.45%)
VolumeN/A
Net Assets1.11B
SAIEX vs SPMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SAIEX vs. SPMGX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAIEX is a StrongBuy and SPMGX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SPMGX has more cash in the bank: 1.11B vs. SAIEX (210M). SAIEX pays higher dividends than SPMGX: SAIEX (16.06) vs SPMGX (5.29). SAIEX was incepted earlier than SPMGX: SAIEX (5 years) vs SPMGX (6 years). SPMGX is a more actively managed with annual turnover of: 32.00 vs. SAIEX (15.00). SPMGX has a lower initial minimum investment than SAIEX: SPMGX (1000) vs SAIEX (100000). SPMGX annual gain was more profitable for investors over the last year : 52.49 vs. SAIEX (34.34).
SAIEXSPMGXSAIEX / SPMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years6 years-
Gain YTD10.0007.306137%
Front LoadN/AN/A-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets210M1.11B19%
Annual Yield % from dividends16.065.29304%
Returns for 1 year34.3452.4965%
Returns for 3 years77.32111.4869%
Returns for 5 yearsN/A126.45-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FINV7.020.04
+0.57%
FinVolution Group
GRFS7.270.03
+0.41%
Grifols SA
INUV0.45N/A
+0.25%
Inuvo
AJG294.82-0.97
-0.33%
Arthur J Gallagher & Co
TRVI3.76-0.02
-0.53%
Trevi Therapeutics